| Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications (NCT01909414) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Metabolic Response of Slow Released Carbohydrates in Diabetes Mellitus (NCT01070238) | University of Giessen | |
| A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea (NCT00001018) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn) (NCT00000631) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis (NCT00002321) | Chiron Corporation | |
| Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 (NCT00000349) | National Institute on Drug Abuse (NIDA) | |
| Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects (NCT00000740) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults (NCT00054860) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult Subjects (NCT00932880) | Torrent Pharmaceuticals Limited | |
| A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions (NCT00992862) | Paddock Laboratories, Inc. | |
| Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents (NCT00412503) | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA) (NCT00000886) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3 (NCT00000857) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies (NCT00051597) | Seagen Inc. | |
| A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions (NCT00693979) | National University Hospital, Singapore | |
| Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer (NCT00496236) | GenVec | |
| A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma (NCT00000725) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects (NCT00000713) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Tai Chi Exercise in Patients With COPD (NCT01027338) | National Center for Complementary and Integrative Health (NCCIH) | |
| The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients (NCT00000962) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Stroke Prevention With Abciximab in Carotid Endarterectomy (NCT00178451) | University of Rochester | |
| A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion (NCT00308477) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children (NCT00000901) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection (NCT00002249) | R W Johnson Pharmaceutical Research Institute | |
| A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection. (NCT00002097) | Argus Pharmaceuticals | |
| Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fasted Conditions (NCT01928056) | Torrent Pharmaceuticals Limited | |
| A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies (NCT00057395) | Aronex Pharmaceuticals | |
| TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma (NCT00243763) | Novartis | |
| A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects (NCT00002428) | United Biomedical | |
| Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32) (NCT00006199) | National Center for Research Resources (NCRR) | |
| Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults (NCT00000904) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| First in Human Study of NI-0701 in Healthy Volunteers (NCT01255501) | Light Chain Bioscience - Novimmune SA | |
| Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy (NCT00000728) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia (NCT00002120) | U.S. Bioscience | |
| Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02055196) | City of Hope Medical Center | |
| Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination (NCT00006153) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS (NCT00000971) | Abbott | |
| A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia (NCT00002009) | Sandoz | |
| Study of Lamotrigine 2 x 25 mg IR Tablets of Torrent Pharmaceuticals Pvt., Ltd., India and Lamictal ® (Lamotrigine) 2 x 25 mg Tablets of Glaxo-SmithKline, USA, in Healthy Human Adult Subjects, Under Fed Conditions (NCT00939458) | Torrent Pharmaceuticals Limited | |
| Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate (NCT00468026) | ProstaPlant Urology System Ltd. | |
| A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT (NCT00000686) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. (NCT00002194) | Boehringer Ingelheim | |
| Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults (NCT00043511) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009) (NCT00001021) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) (NCT00001041) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Tolerability of the Vaginal Gel PRO 2000/5 (NCT00006207) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Test the Safety of Three Experimental HIV Vaccines (NCT00000946) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers (NCT00000847) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer (NCT00116155) | Cell Genesys | |
| Phase I/II Study of Curdlan Sulfate (NCT00002100) | AJI Pharma USA | |
| A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants (NCT00000944) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) (NCT00002036) | Abbott | |
| A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults (NCT02001584) | Gedeon Richter Plc. | |
| A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV) (NCT00002014) | Glaxo Wellcome | |
| A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers (NCT00000774) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) (NCT00320827) | Daiichi Sankyo | |
| Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions (NCT01990586) | Torrent Pharmaceuticals Limited | |
| Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects (NCT00091741) | Georgetown University | |
| An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC) (NCT00002255) | Amgen | |
| A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex (NCT00000710) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy (NCT00002422) | Harbor Therapeutics | |
| A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease. (NCT00002115) | Gilead Sciences | |
| The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex (NCT00000986) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer (NCT00040560) | Copharos | |
| Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam (NCT02800824) | Padagis LLC | |
| Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer (NCT00103831) | Bristol-Myers Squibb | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 (NCT00002137) | Daiichi Pharmaceuticals | |
| Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00021307) | Fox Chase Cancer Center | |
| A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus) (NCT01096199) | National University Hospital, Singapore | |
| The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children (NCT00000843) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency (NCT00228852) | Emory University | |
| A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months (NCT00000749) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex (NCT00000976) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102 (NCT00048217) | Trimeris | |
| Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study (NCT00863005) | Moberg Pharma AB | |
| Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions. (NCT01089205) | Torrent Pharmaceuticals Limited | |